U.S. pharma big copyright scrapped two experimental weight loss drugs last yr—a as soon as-everyday capsule, lotiglipron, due to elevated liver enzymes as well as a two times-day-to-day pill, danuglipron, as a result of potent Negative effects—but CEO Albert Bourla has explained the